Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 43)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
30-Nov-09Freedonia Group Inc, TheThe Freedonia GroupFreedonia Focus on Weight Loss Products & Services24$500  View Abstract
24-Nov-09New Constructs, LLCN/AAMLN: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10  View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299  View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71$199  View Abstract
22-Nov-09Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (Global)148$169  View Abstract
22-Nov-09Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (North America)103$169  View Abstract
22-Nov-09Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (United States)101$169  View Abstract
22-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: AMYLIN PHARMACEUTICALS INC5$25  View Abstract
20-Nov-09Ford Investor Services, Inc.N/AValue Graph: AMYLIN PHARM -- AMLN1$4  View Abstract
20-Nov-09Ford Investor Services, Inc.N/AIndustry Value Graph: ACUR , AMLN , LCI , MTXX , NRGN , SLXP -- DRUGS3$4  View Abstract
Next 20

Brokerage Reports (Showing 1 to 7 of 7)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
13-Nov-09Thomson StreetEventsN/AAMLN - Event Transcript of Amylin Pharmaceuticals, Inc. conference call, Nov. 11, 2009 / 10:00am ET8$75  View Abstract
2-Nov-09Collins Stewart LLCSalveen J. Kochnover CFAUpdated Byetta Label and Obesity Partnership; Overhang Remains2$10  View Abstract
27-Oct-09Thomson StreetEventsN/AAMLN - Event Transcript of Amylin Pharmaceuticals, Inc. conference call, Oct. 26, 2009 / 9:30am ET7$75  View Abstract
21-Oct-09Collins Stewart LLCSalveen J. Kochnover CFA3Q09 Earnings: Byetta Falls Short but Focus Remains on EQW6$25  View Abstract
21-Oct-09Thomson StreetEventsN/AAMLN - Event Transcript of Amylin Pharmaceuticals, Inc. conference call, Oct. 20, 2009 / 5:00pm ET11$75  View Abstract
21-Oct-09Thomson StreetEventsN/AAMLN - Event Brief of Amylin Pharmaceuticals, Inc. conference call, Oct. 20, 2009 / 5:00pm ET13$75  View Abstract
16-Oct-09Collins Stewart LLCSalveen J. Kochnover CFA3Q09 EPS Preview: Expect Flat Byetta QoQ Sales4$10  View Abstract

Independent Reports (Showing 1 to 10 of 36)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
30-Nov-09Freedonia Group Inc, TheThe Freedonia GroupFreedonia Focus on Weight Loss Products & Services24$500View Abstract
24-Nov-09New Constructs, LLCN/AAMLN: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71$199View Abstract
22-Nov-09Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (Global)148$169View Abstract
22-Nov-09Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (North America)103$169View Abstract
22-Nov-09Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (United States)101$169View Abstract
22-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: AMYLIN PHARMACEUTICALS INC5$25View Abstract
20-Nov-09Ford Investor Services, Inc.N/AValue Graph: AMYLIN PHARM -- AMLN1$4View Abstract
20-Nov-09Ford Investor Services, Inc.N/AIndustry Value Graph: ACUR , AMLN , LCI , MTXX , NRGN , SLXP -- DRUGS3$4View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.